1. Steatotic and Steatohepatitic Hepatocellular Carcinomas
    Umut Aykutlu et al, 2021, American Journal of Surgical Pathology CrossRef
  2. The High-Sensitivity C-Reactive Protein/Albumin Ratio Predicts Long-Term Oncologic Outcomes after Curative Resection for Hepatocellular Carcinoma
    Tak Oh et al, 2018, Journal of Clinical Medicine CrossRef
  3. New indexes derived from routine blood tests and their clinical application in hepatocellular carcinoma
    Qing-Qing Luo et al, 2022, Clinics and Research in Hepatology and Gastroenterology CrossRef
  4. IL-6 and NFE2L2: A putative role for the hepatoprotective effect of N. Sativa, P. Ginseng and C. Sempervirens in AFB-1 induced hepatocellular carcinoma in rats
    Nora M. Aborehab et al, 2019, Toxicology Reports CrossRef
  5. Hepatocellular Carcinoma in 2021: An Exhaustive Update
    Cyriac A Philips et al, 2021, Cureus CrossRef
  6. New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma
    Ting Wang et al, 2020, Frontiers in Oncology CrossRef
  7. HCC-Mark: a simple non-invasive model based on routine parameters for predicting hepatitis C virus related hepatocellular carcinoma
    M Omar et al, 2021, British Journal of Biomedical Science CrossRef
  8. Early C‐reactive Protein Kinetics Predict Response to Immune Checkpoint Blockade in Unresectable Hepatocellular Carcinoma
    Qiuying Qin et al, 2023, Journal of Hepatocellular Carcinoma CrossRef
  9. Neutrophil-to-Lymphocyte Ratio Can Distinguish Patients with Liver Cirrhosis from Healthy People but Cannot Distinguish Patients with Cirrhotic Hepatocellular Carcinoma from Patients with Liver Cirrhosis
    Xuming Zhu et al, 2022, Journal of Hepatocellular Carcinoma CrossRef
  10. Evaluation of C-reactive protein and platelet–lymphocyte ratio as potential tumor markers in Egyptian patients with hepatocellular carcinoma
    Nada F. Abd Elkawy et al, 2022, Tanta Medical Journal CrossRef
  11. CRP Levels in Viral Hepatitis: A Meta-Analysis Study
    Sukhpal Singh et al, 2020, International Journal of Infection CrossRef
  12. CRAFITY score benefits hepatocellular carcinoma patients treated with transarterial chemoembolization and lenvatinib
    Lin Zhang et al, 2024, Cancer Medicine CrossRef